OBJECTIVES: Glaucoma is the leading cause of irreversible visual impairment worldwide. Glaucoma surgical devices fail due to a scarring response that results in fibrous encapsulation surrounding the device preventing aqueous humour drainage. 3D printing technology has the potential to develop personalised ophthalmic devices or organs with improved cost effectiveness and productivity. Limited experimental data exists as to the biocompatibility response of 3D printed photopolymers. We performed cell adhesion and protein adsorption studies of 3D printed photopolymers and materials used in current ophthalmic devices (Silicone, Polytetrafluoroethylene (PTFE) and Poly (methyl methacrylate) (PMMA)). We aimed to assess 3D printed materials as a potential route for ophthalmic device development. METHODS: RESULTS: